Navigation Links
Top FDA Officials Were Not Part Of Plan B Decision

The former U.S. Food and Drug Administration chief Commissioner Lester Crawford prevented two senior officials// from deciding the course of action on Barr Pharmaceuticals Inc.'s Plan B, which is a 'morning after' pill.

These statements were contained in the transcripts released by the non-profit Center for Reproductive Rights. Dr. Steven Galson, director of the FDA's Center for Drug Evaluation and Research said that he was thing of approving the action to sell Plan B as a OTC drug. But Crawford "told me that he was concerned about where we were heading because he knew that I was heading towards this recommendation, and he told me that he was going to make the decision on what to do with the application."

He said that Crawford was apparently concerned about the packaging of the drug. Plan B is an emergency pill that can prevent conception if taken within 72 hours after sexual intercourse. Crawford was confirmed in July 2005, but resigned abruptly in September 2005.

Dr. Janet Woodcock, a deputy FDA commissioner also said that she repeatedly asked Crawford about Plan B. "Ordinarily, I would have been more involved, but not in all cases. In this case, I was not involved," Woodcock, said. The Center for Reproductive Rights said that the FDA behaved unusually in this case. "The more we learn about the FDA's decision-making around Plan B, the more we know that the agency violated its own precedents," attorney Simon Heller said.
'"/>




Page: 1

Related medicine news :

1. Health Officials Recommend Flu Vaccine
2. Nutrient Profiling System Launched By Food Officials in UK
3. US Officials To Discuss Effectiveness Of Plan To Face Bird Flu Threat
4. Health Officials Inquire Into OraQuick HIV Tests
5. Officials In Turkey Confirm Deaths Due To Bird Flu
6. Chinese Health Officials To Discuss Preparation Of Bird Flu
7. Bihar Health Officials Worried As Polio Cases Soar
8. Medical Ethics Violated By Prison Officials In Guantanamo Bay
9. Wal-Mart under Pressure from Health Care Officials
10. Minister Suspends 13 Officials For Pulse Polio Laxity
11. Health Officials Defend Their Decision To House Patients In Hotels
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... ... 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned ... the David Geffen School of Medicine at UCLA. He trained in Internal Medicine at ... fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June ... with. The article goes on to state that individuals are now more comfortable seeking ... common operations such as calf and cheek reduction. The Los Angeles area medical group, ...
(Date:6/24/2016)... Dallas, Texas (PRWEB) , ... June 24, 2016 ... ... 12th International Conference and Scientific Sessions in Dallas that it will receive two ... Announcement of the grants came as PHA marked its 25th anniversary by recognizing ...
(Date:6/24/2016)... ... 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join ... wage raise to $12 an hour by 2020 and then adjusting it yearly to increase ... of the minimum wage, assure the wage floor does not erode again, and make future ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... The Grove Investment Group (TGIG), has initiated cultivation and processing operations at its ... Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of a complete system ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Research and Markets has announced the addition of ... report to their offering. ... The World Market for Companion Diagnostics covers the world market ... the report includes the following: , World ... Region (N. America, EU, ROW), 2015-2020 , World IVD ...
(Date:6/24/2016)... LEXINGTON, Mass. , June 24, 2016   ... specialty pharmaceutical company developing innovative inhaled drugs, announced today ... when Russell Investments reconstituted its comprehensive set ... 2016. "This is an important milestone for ... "It will increase shareholder awareness of our progress in ...
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
Breaking Medicine Technology: